Copyright Reports & Markets. All rights reserved.

Global Mesalazine Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Mesalazine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Mesalazine Market Size Growth Rate by Type
    • 1.4.2 Purity ≥ 97 %
    • 1.4.3 Purity ≥ 98 %
    • 1.2.4 Purity ≥ 99 %
  • 1.3 Market by Application
    • 1.3.1 Global Mesalazine Market Size Growth Rate by Application
    • 1.3.2 Mesalazine Tablets
    • 1.3.3 Mesalazine Capsules
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Mesalazine Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Mesalazine Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Mesalazine Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Mesalazine Regions by Sales
    • 2.4.1 Global Top Mesalazine Regions by Sales (2016-2021)
    • 2.4.2 Global Top Mesalazine Regions by Sales (2022-2027)
  • 2.5 Global Top Mesalazine Regions by Revenue
    • 2.5.1 Global Top Mesalazine Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Mesalazine Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Mesalazine Sales by Manufacturers
    • 3.1.1 Global Top Mesalazine Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Mesalazine Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Mesalazine Sales in 2020
  • 3.2 Global Mesalazine Revenue by Manufacturers
    • 3.2.1 Global Top Mesalazine Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Mesalazine Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Mesalazine Revenue in 2020
  • 3.3 Global Mesalazine Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Mesalazine Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Mesalazine Sales by Type
    • 4.1.1 Global Mesalazine Historical Sales by Type (2016-2021)
    • 4.1.2 Global Mesalazine Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Mesalazine Sales Market Share by Type (2016-2027)
  • 4.2 Global Mesalazine Revenue by Type
    • 4.2.1 Global Mesalazine Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Mesalazine Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Mesalazine Revenue Market Share by Type (2016-2027)
  • 4.3 Global Mesalazine Price by Type
    • 4.3.1 Global Mesalazine Price by Type (2016-2021)
    • 4.3.2 Global Mesalazine Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Mesalazine Sales by Application
    • 5.1.1 Global Mesalazine Historical Sales by Application (2016-2021)
    • 5.1.2 Global Mesalazine Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Mesalazine Sales Market Share by Application (2016-2027)
  • 5.2 Global Mesalazine Revenue by Application
    • 5.2.1 Global Mesalazine Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Mesalazine Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Mesalazine Revenue Market Share by Application (2016-2027)
  • 5.3 Global Mesalazine Price by Application
    • 5.3.1 Global Mesalazine Price by Application (2016-2021)
    • 5.3.2 Global Mesalazine Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Mesalazine Market Size by Type
    • 6.1.1 North America Mesalazine Sales by Type (2016-2027)
    • 6.1.2 North America Mesalazine Revenue by Type (2016-2027)
  • 6.2 North America Mesalazine Market Size by Application
    • 6.2.1 North America Mesalazine Sales by Application (2016-2027)
    • 6.2.2 North America Mesalazine Revenue by Application (2016-2027)
  • 6.3 North America Mesalazine Market Size by Country
    • 6.3.1 North America Mesalazine Sales by Country (2016-2027)
    • 6.3.2 North America Mesalazine Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Mesalazine Market Size by Type
    • 7.1.1 Europe Mesalazine Sales by Type (2017-2027)
    • 7.1.2 Europe Mesalazine Revenue by Type (2017-2027)
  • 7.2 Europe Mesalazine Market Size by Application
    • 7.2.1 Europe Mesalazine Sales by Application (2017-2027)
    • 7.2.2 Europe Mesalazine Revenue by Application (2017-2027)
  • 7.3 Europe Mesalazine Market Size by Country
    • 7.3.1 Europe Mesalazine Sales by Country (2017-2027)
    • 7.3.2 Europe Mesalazine Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Mesalazine Market Size by Type
    • 8.1.1 Asia Pacific Mesalazine Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Mesalazine Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Mesalazine Market Size by Application
    • 8.2.1 Asia Pacific Mesalazine Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Mesalazine Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Mesalazine Market Size by Region
    • 8.3.1 Asia Pacific Mesalazine Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Mesalazine Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Mesalazine Market Size by Type
    • 9.1.1 Latin America Mesalazine Sales by Type (2019-2027)
    • 9.1.2 Latin America Mesalazine Revenue by Type (2019-2027)
  • 9.2 Latin America Mesalazine Market Size by Application
    • 9.2.1 Latin America Mesalazine Sales by Application (2019-2027)
    • 9.2.2 Latin America Mesalazine Revenue by Application (2019-2027)
  • 9.3 Latin America Mesalazine Market Size by Country
    • 9.3.1 Latin America Mesalazine Sales by Country (2019-2027)
    • 9.3.2 Latin America Mesalazine Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Mesalazine Market Size by Type
    • 6.1.1 Middle East and Africa Mesalazine Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Mesalazine Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Mesalazine Market Size by Application
    • 6.2.1 Middle East and Africa Mesalazine Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Mesalazine Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Mesalazine Market Size by Country
    • 6.3.1 Middle East and Africa Mesalazine Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Mesalazine Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Syntese A/S
    • 11.1.1 Syntese A/S Corporation Information
    • 11.1.2 Syntese A/S Overview
    • 11.1.3 Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Syntese A/S Mesalazine Product Description
    • 11.1.5 Syntese A/S Related Developments
  • 11.2 Divis Laboratories
    • 11.2.1 Divis Laboratories Corporation Information
    • 11.2.2 Divis Laboratories Overview
    • 11.2.3 Divis Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Divis Laboratories Mesalazine Product Description
    • 11.2.5 Divis Laboratories Related Developments
  • 11.3 Cambrex Corporation
    • 11.3.1 Cambrex Corporation Corporation Information
    • 11.3.2 Cambrex Corporation Overview
    • 11.3.3 Cambrex Corporation Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Cambrex Corporation Mesalazine Product Description
    • 11.3.5 Cambrex Corporation Related Developments
  • 11.4 Ipca Laboratories
    • 11.4.1 Ipca Laboratories Corporation Information
    • 11.4.2 Ipca Laboratories Overview
    • 11.4.3 Ipca Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Ipca Laboratories Mesalazine Product Description
    • 11.4.5 Ipca Laboratories Related Developments
  • 11.5 PharmaZell
    • 11.5.1 PharmaZell Corporation Information
    • 11.5.2 PharmaZell Overview
    • 11.5.3 PharmaZell Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 PharmaZell Mesalazine Product Description
    • 11.5.5 PharmaZell Related Developments
  • 11.6 Lasa Loboratory
    • 11.6.1 Lasa Loboratory Corporation Information
    • 11.6.2 Lasa Loboratory Overview
    • 11.6.3 Lasa Loboratory Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Lasa Loboratory Mesalazine Product Description
    • 11.6.5 Lasa Loboratory Related Developments
  • 11.7 Erregierre SpA
    • 11.7.1 Erregierre SpA Corporation Information
    • 11.7.2 Erregierre SpA Overview
    • 11.7.3 Erregierre SpA Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Erregierre SpA Mesalazine Product Description
    • 11.7.5 Erregierre SpA Related Developments
  • 11.8 Corden Pharma Bergamo
    • 11.8.1 Corden Pharma Bergamo Corporation Information
    • 11.8.2 Corden Pharma Bergamo Overview
    • 11.8.3 Corden Pharma Bergamo Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Corden Pharma Bergamo Mesalazine Product Description
    • 11.8.5 Corden Pharma Bergamo Related Developments
  • 11.9 CTX Lifescience
    • 11.9.1 CTX Lifescience Corporation Information
    • 11.9.2 CTX Lifescience Overview
    • 11.9.3 CTX Lifescience Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 CTX Lifescience Mesalazine Product Description
    • 11.9.5 CTX Lifescience Related Developments
  • 11.10 Ishita Active Pharma Ingredients
    • 11.10.1 Ishita Active Pharma Ingredients Corporation Information
    • 11.10.2 Ishita Active Pharma Ingredients Overview
    • 11.10.3 Ishita Active Pharma Ingredients Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Ishita Active Pharma Ingredients Mesalazine Product Description
    • 11.10.5 Ishita Active Pharma Ingredients Related Developments
  • 11.1 Syntese A/S
    • 11.1.1 Syntese A/S Corporation Information
    • 11.1.2 Syntese A/S Overview
    • 11.1.3 Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Syntese A/S Mesalazine Product Description
    • 11.1.5 Syntese A/S Related Developments
  • 11.12 Xinxiang Tianfeng Fine Chemical
    • 11.12.1 Xinxiang Tianfeng Fine Chemical Corporation Information
    • 11.12.2 Xinxiang Tianfeng Fine Chemical Overview
    • 11.12.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Xinxiang Tianfeng Fine Chemical Product Description
    • 11.12.5 Xinxiang Tianfeng Fine Chemical Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Mesalazine Value Chain Analysis
  • 12.2 Mesalazine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Mesalazine Production Mode & Process
  • 12.4 Mesalazine Sales and Marketing
    • 12.4.1 Mesalazine Sales Channels
    • 12.4.2 Mesalazine Distributors
  • 12.5 Mesalazine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Mesalazine Industry Trends
  • 13.2 Mesalazine Market Drivers
  • 13.3 Mesalazine Market Challenges
  • 13.4 Mesalazine Market Restraints

14 Key Findings in The Global Mesalazine Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Mesalazine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mesalazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Purity ≥ 97 %
    Purity ≥ 98 %
    Purity ≥ 99 %
    According to the type, purity ≥ 98% is the highest, reaching 48.44% in 2019.

    Segment by Application
    Mesalazine Tablets
    Mesalazine Capsules
    Others
    Mesalazine tablets has the highest market share in terms of application, at 50.61% in 2019.

    By Company
    Syntese A/S
    Divis Laboratories
    Cambrex Corporation
    Ipca Laboratories
    PharmaZell
    Lasa Loboratory
    Erregierre SpA
    Corden Pharma Bergamo
    CTX Lifescience
    Ishita Active Pharma Ingredients
    YC Biotech (Jiangsu)
    Xinxiang Tianfeng Fine Chemical

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now